Summary
The product Tren A, from an Axle Labs manufacturer, underwent independent microbiological testing to determine its sterility and safety. The sample, identified by batch number 010, was submitted by Axle Labs and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The TAMC (Total Aerobic Microbial Count) and TYMC (Total Yeast and Mold Count) tests were conducted, and the sample passed both tests, confirming that it meets microbiological safety standards.
The testing process began on 09 January 2025, with the sample received on 15 January 2025, and the analysis completed on 28 January 2025. The results confirm that the product meets sterility standards, supporting its microbiological safety for intended use. However, ongoing batch-to-batch testing remains essential to maintain product reliability. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Axle Labs
- Product Name: Tren A
- Batch Number: 010
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #56036
- Testing Ordered: 09 January 2025
- Sample Received: 15 January 2025
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Axle Labs (manufacturer)
- Analysis Paid For By: Axle Labs (manufacturer)
Testing Results
- TAMC (Total Aerobic Microbial Count): Pass
- TYMC (Total Yeast and Mold Count): Pass
Verification Details
- Verification URL: https://janoshik.com/tests/56036_TA7US7QFZ8X3
Evaluation of Manufacturer-Submitted Testing
The microbiological testing results confirm that Tren A meets sterility standards, with no detectable contamination of bacteria, yeast, or mold. These findings indicate that proper sterile production methods were likely followed for this batch. However, as the manufacturer remains Axle Labs, independent verification through additional sterility testing across multiple batches is recommended.
Janoshik Analytical follows strict transparency and quality control protocols, but further evaluation over time can help ensure consistency and long-term product safety.
Conclusion
The analysis verifies that Tren A passed the TAMC and TYMC tests, demonstrating compliance with microbiological safety standards. While this batch meets sterility expectations, ongoing testing is crucial to confirm long-term consistency and reliability across multiple productions. This report is published to support educational and harm reduction efforts, helping consumers make informed choices regarding pharmaceutical products.
Disclaimer
This report is published for educational and harm reduction purposes. The analysis results are based on a single sample, and variations between batches may exist. Since the manufacturer is Axle Labs, independent verification from additional third-party laboratories is strongly encouraged. Readers should use this information responsibly and consult professional guidance when assessing pharmaceutical products.
